share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goodman Tony

SEC announcement ·  Mar 27 18:10
Summary by Moomoo AI
Tony Goodman, the Chief Operating Officer of Adial Pharmaceuticals, Inc. (ADIL), was reported to have engaged in a transaction involving the company's stock on March 25, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The number of shares held by Goodman after the transaction was also not provided. This information is crucial for investors to understand the insider activity within Adial Pharmaceuticals and may influence their investment decisions.
Tony Goodman, the Chief Operating Officer of Adial Pharmaceuticals, Inc. (ADIL), was reported to have engaged in a transaction involving the company's stock on March 25, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The number of shares held by Goodman after the transaction was also not provided. This information is crucial for investors to understand the insider activity within Adial Pharmaceuticals and may influence their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more